Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Seoane

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
The m<sup>6</sup>A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressorYiren Xiao, Kaushik N Thakkar, Hongjuan Zhao, et al.
Molecular Cell|May 5, 2022
The Mettl3 epitranscriptomic writer amplifies p53 stress responsesNitin Raj, Mengxiong Wang, Jose A Seoane, et al.
Nature|July 19, 2023
p53 governs an AT1 differentiation programme in lung cancer suppressionAlyssa M Kaiser, Alberto Gatto, Kathryn J Hanson, et al.
Cancer Research|March 11, 2026
Inactivation of CDKN2AARF Promotes p53-Independent Remodeling of the PDAC Tumor MicroenvironmentSofia Ferreira, Brittany M Flowers, Won-Young Choi, et al.
Cancer Cell|October 11, 2017
A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic CancerStephano S Mello, Liz J Valente, Nitin Raj, et al.
Cell Reports|November 3, 2023
Functional screening of amplification outlier oncogenes in organoid models of early tumorigenesisAmeen A Salahudeen, Jose A Seoane, Kanako Yuki, et al.
The Journal of Clinical Investigation|November 25, 2025
Estrogen Receptor signaling drives immune evasion and immunotherapy resistance in HR+ breast cancerJosé Ángel Palomeque, Gabriel Serra-Mir, Sandra Blasco-Benito, et al.
Nature|March 15, 2019
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroupsOscar M Rueda, Stephen-John Sammut, Jose A Seoane, et al.
Cancer Discovery|January 16, 2021
A CRISPR/Cas9-Engineered <i>ARID1A</i>-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic TransformationYuan-Hung Lo, Kevin S Kolahi, Yuhong Du, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2025
Molecular and clinical analyses of gene fusions identify therapeutic targets in paired primary and metastatic breast cancer from the AURORA program (BIG 14-01)Chiara Biagioni, Danai Fimereli, Alexandre Irrthum, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
The m<sup>6</sup>A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressorYiren Xiao, Kaushik N Thakkar, Hongjuan Zhao, et al.
Molecular Cell|May 5, 2022
The Mettl3 epitranscriptomic writer amplifies p53 stress responsesNitin Raj, Mengxiong Wang, Jose A Seoane, et al.
Nature|July 19, 2023
p53 governs an AT1 differentiation programme in lung cancer suppressionAlyssa M Kaiser, Alberto Gatto, Kathryn J Hanson, et al.
Cancer Research|March 11, 2026
Inactivation of CDKN2AARF Promotes p53-Independent Remodeling of the PDAC Tumor MicroenvironmentSofia Ferreira, Brittany M Flowers, Won-Young Choi, et al.
Cancer Cell|October 11, 2017
A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic CancerStephano S Mello, Liz J Valente, Nitin Raj, et al.
Cell Reports|November 3, 2023
Functional screening of amplification outlier oncogenes in organoid models of early tumorigenesisAmeen A Salahudeen, Jose A Seoane, Kanako Yuki, et al.
The Journal of Clinical Investigation|November 25, 2025
Estrogen Receptor signaling drives immune evasion and immunotherapy resistance in HR+ breast cancerJosé Ángel Palomeque, Gabriel Serra-Mir, Sandra Blasco-Benito, et al.
Nature|March 15, 2019
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroupsOscar M Rueda, Stephen-John Sammut, Jose A Seoane, et al.
Cancer Discovery|January 16, 2021
A CRISPR/Cas9-Engineered <i>ARID1A</i>-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic TransformationYuan-Hung Lo, Kevin S Kolahi, Yuhong Du, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2025
Molecular and clinical analyses of gene fusions identify therapeutic targets in paired primary and metastatic breast cancer from the AURORA program (BIG 14-01)Chiara Biagioni, Danai Fimereli, Alexandre Irrthum, et al.
Pageof 11